Buffalo BioLabs, LLC (BBL) is an experienced preclinical Contract Research Organization (CRO) focused on the expert management and performance of in vitro and in vivo studies capable of bringing new therapeutic agents to the stage of clinical testing. Currently, BBL is involved primarily in animal studies in the field of oncology. Over the next two years, principals of the firm are targeting the release of a panel of PDX models. An important and useful resource to the firm is the close proximity and existing relationships with researchers and clinicians at Roswell Park Cancer Institute, the nation's first cancer center and still a leader in cancer care and research, to build an outstanding offering in this area of research .
